Clinical and epidemiological characteristics of pediatric patients with acute bronchiolitis hospitalized in a referral hospital
DOI:
https://doi.org/10.53732/rccsalud/2025.e7118Keywords:
bronchiolitis, respiratory syncytial virus, infant, risk factors, epidemiologyAbstract
Introduction. Acute bronchiolitis is the leading cause of hospitalization in infants and represents a major burden for the public health system in Paraguay. Objective: To determine the clinical, sociodemographic, and outcome characteristics of pediatric patients hospitalized for bronchiolitis in the Emergency Department of the Hospital Nacional de Itauguá during 2023–2024. Materials and Methods. A retrospective observational study was conducted including 151 patients aged 0–24 months admitted with acute bronchiolitis. Demographic, clinical, and outcome variables were analyzed using descriptive statistics. Results. Median age was 3 months (IQR: 2–6), with a male predominance (59.6%). Prematurity was recorded in 15.9% of patients. Hospital admissions peaked in winter (62.9%). Respiratory Syncytial Virus (RSV) was the most frequently detected pathogen (31.1%), while no etiologic agent was identified in 49% of cases. According to the TAL scale, 62.3% had moderate severity, and 88.1% required oxygen therapy. Median hospital stay was 3 days (IQR: 2–4). Conclusion. Bronchiolitis predominantly affects male infants, especially those born prematurely, and follows a clear winter seasonal pattern. The high proportion of cases without etiologic diagnosis underscores the need to strengthen viral detection capacity, epidemiological surveillance, and clinical management strategies.
References
Meissner HC. Viral bronchiolitis in children. N Engl J Med. 2016;374(1):62–72. https://doi.org/10.1056/NEJMra1413456
Florin TA, Plint AC, Zorc JJ. Viral bronchiolitis. Lancet. 2017;389(10065):211–24. https://doi.org/10.1016/S0140-6736(16)30951-5
Øymar K, Skjerven HO, Mikalsen IB. Acute bronchiolitis in infants, a review. Scand J Trauma Resusc Emerg Med. 2014;22:23. https://doi.org/10.1186/1757-7241-22-23
Hasegawa K, Tsugawa Y, Brown DFM, Mansbach JM, Camargo CA. Trends in Bronchiolitis Hospitalizations in the United States, 2000–2009. Pediatrics. 2013;132(1):28–36. https://doi.org/10.1542/peds.2012-3877
Ciapponi A, Palermo MC, Sandoval MM, et al. Respiratory syncytial virus disease burden in children and adults from Latin America: a systematic review and meta-analysis. Front Public Health. 2024;12:1377968. https://doi.org/10.3389/fpubh.2024.1377968
Jartti T, Gern JE. Role of viral infections in the development and exacerbation of asthma in children. J Allergy Clin Immunol. 2017;140(4):895–906. https://doi.org/10.1016/j.jaci.2017.08.003
Ralston SL, Lieberthal AS, Meissner HC, Alverson BK; Baley JE; Gadomski AM, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014;134(5):e1474–502. https://doi.org/10.1542/peds.2014-2742
Ministerio de Salud Pública y Bienestar Social de Paraguay. Se incrementan hospitalizaciones por virus sincitial respiratorio. Asunción: MSPBS; 2023. https://www.mspbs.gov.py/portal/27352/se-incrementan-hospitalizaciones-por-virus-sincitial-respiratorio.html
Chamorro SCI. Prevalencia y características clínico-epidemiológicas de la bronquiolitis aguda en niños hospitalizados en el Hospital Regional de Coronel Oviedo “Dr. José Ángel Samudio” [Tesis de grado]. Coronel Oviedo: Universidad Nacional de Caaguazú; 2016. https://repositorio.fcmunca.edu.py/xmlui/handle/123456789/91
Mareco Herrero CM, Insaurralde Báez RE, Lezcano Peralta C. Manejo inicial de la bronquiolitis aguda grave en el Hospital Central del Instituto de Previsión Social entre enero a junio 2019. Rev. cient. cienc. salud. 2020;2(2):11–8. https://doi.org/10.53732/rccsalud/02.02.2020.11
Manti S, Staiano A, Orfeo L, Midulla F, Marseglia GL, Ghizzi C, et al. UPDATE - 2022 Italian guidelines on the management of bronchiolitis in infants. Ital J Pediatr. 2023;49:19. https://doi.org/10.1186/s13052-022-01392-6
Asociación Médica Mundial. Declaración de Helsinki de la AMM: Principios éticos para las investigaciones médicas en seres humanos. 2013. https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/
Martins Filho SL, de Oliveira SL, Fernandes Gomes da Silva MT, Barreto Román SA. Prevalencia, características clínicas y factores asociados a bronquiolitis en niños menores de 2 años en el Hospital General Santa Rosa del Aguaray en el año de 2021. Rev Medicinae Signum. 2023;2(1):52-61. https://revistas.unc.edu.py/index.php/fmunc/article/view/174
Dalziel SR, Haskell L, O'Brien S, Borland ML, Plint AC, Babl FE, et al. Bronchiolitis. Lancet. 2022;400(10349):392–406. https://doi.org/10.1016/S0140-6736(22)01016-9
Cleak TS, Ballot DE. RSV bronchiolitis in 2018: A descriptive study of children admitted to two Johannesburg tertiary hospitals. S Afr J Child Health. 2023;17(3):141-145. https://doi.org/10.7196/SAJCH.2023.v17i3.1984
Wollmeister E, Machado AS, Urrutia-Pereira M, Mocellin M, Mallmann L, Simon L, et al. Respiratory syncytial virus in Brazilian infants: Ten years, two cohorts. J Clin Virol. 2018;98:33–36. https://doi.org/10.1016/j.jcv.2017.12.002
Menezes RC, Leite ÁJ, Cardoso AM, Almeida PR, Silva LR, Pacheco FC, et al. Severe viral lower respiratory tract infections in Brazilian children: Clinical features of a national cohort. J Infect Public Health. 2024;17(1):192-199. https://doi.org/10.1016/j.jiph.2023.09.015
Hammitt LL, Dagan R, Yuan Y, Manuel Baca M, Bosheva M, Madhi SA, et al. Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants. N Engl J Med. 2022;386(9):837–846. https://doi.org/10.1056/NEJMoa2110275
Drysdale SB, Cathie K, Flamein F, Knuf M, Collins AM, Hill HC, et al. Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants. N Engl J Med. 2023;389(26):2425-35. https://doi.org/10.1056/NEJMoa2309189
Ministerio de Salud Pública y Bienestar Social de Paraguay. Salud implementa nirsevimab para la prevención del Virus Respiratorio Sincitial (VRS) en Paraguay. Asunción: MSPBS; 2024. https://www.mspbs.gov.py/portal/32606/salud-implementa-nirsevimab-para-la-prevencion-del-virus-respiratorio-sincitial-vrs-en-paraguay.html
Giachetto G, Vomero A, Pandolfo S, Notejane M, García L, Pérez E. Validación del score clínico de Tal modificado para la evaluación de severidad en bronquiolitis. Arch Pediatr Urug. 2018;89(Supl 1):S40–7. https://www.sup.org.uy/archivos-de-pediatria/adp89-s1/web/pdf/adp.2018.89.s1.a05.pdf
 
						 
							
 
			
		 
			 
			 
				














 All the contents of this journal are licensed under a
  All the contents of this journal are licensed under a 